Latest Videos |view all videos
Examining Spruelike Symptoms Associated with Olmesartan
Joseph A. Murray, MD, and Charanjit (Chet) Rihal, MD, MBA, discuss the differentiation between symptoms from celiac disease versus a medication, olmesartan.
High-intensity interval training for people with CAD: What risks? What benefits?
Ray W. Squires, Ph.D., and Steve R. Ommen, M.D., weigh the potential risks and benefits of the hot topic of high-intensity interval training in treatment of cardiovascular disease.
Charanjit S. Rihal, M.D., and Thomas G. Allison, Ph.D., discuss the role of exercise in promoting cardiac health and how oxygen treadmill testing can help discern cardiac versus conditioning causes of dyspnea.
In a video originally posted on TheHeart.org | Medscape Cardiology, Vuyisile T. Nkomo, M.D., M.P.H., interviews David R. Holmes Jr., M.D., on the transcatheter valve therapy (TVT) registry and CHOICE trial data from the American College ...
AAPMR 2011 Meeting- Mary Pyfferoen Discusses Poster
Mary Pyfferoen, P.T., of Mayo Clinic, discussed her AAPMR poster presentation, titled "Inpatient Rehabilitation in Patients Receiving Left Ventricular Assist Device Therapy."
Surgical management of hypertrophic cardiomyopathy
Steve R. Ommen, M.D., and Hartzell V. Schaff, M.D., retrace the evolution of hypertrophic cardiomyopathy from the first procedure done at Mayo Clinic to current management.
Cardioncology: What every cardiologist should know
Amir Lerman, M.D., and Joerg Herrman, M.D., discuss the emerging field of cardioncology that is developing as oncology patients live longer and possible treatment approaches.
Repair or Replacement in Ischemic Mitral Regurgitation?
Robert Widmer, MD, PhD, and Rakesh M. Suri, MD, DPhil discuss the practical takeaways from a recent study comparing valve repair with valve replacement in patients with severe ischemic MR.
Marfan syndrome: New challenges
Bernard J. Gersh, M.B., Ch.B., D.Phil., interviews Juan M. Bowen, M.D., about the often undiagnosed Marfan syndrome and, in spite of a much improved chance of a normal life span, the risk of sudden death remains for untreated individuals.